Science Explorer Back to mapMap
Discussion
Company · Menlo Park · United States

PharmatrophiX (United States)

pharmatrophix.comROR OpenAlex
Research works
36
▲ 115% vs 2018-21
Citations
498
13.7 per fractional work
Top-10% rate
15.1%
all institutions 10.0%
Open access
31%
world 40%
International
22%
world 18%
PharmatrophiX (United States)

Not ranked overall: PharmatrophiX (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does PharmatrophiX (United States) work in?

In all years, 37% of research at PharmatrophiX (United States) is in Health Sciences, 22% in Life Sciences. Its largest fields are Medicine (31%), Biochemistry, Genetics and Molecular Biology (18%), Social Sciences (10%). It does 1.4× the world's share of Health Sciences.

Health Sciences: 13 fractional works · 36.7% of its workMedicine: 11 fractional works · 30.9% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 4.6% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 4.2% of its workReproductive Medicine: 1 fractional works · 3.9% of its workSurgery: 1 fractional works · 2.5% of its workOncology: 1 fractional works · 1.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.9% of its workPharmacology: 1 fractional works · 1.7% of its workHealth Informatics: 1 fractional works · 1.5% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.3% of its workPathology and Forensic Medicine: 0 fractional works · 1.2% of its workComplementary and alternative medicine: 0 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.8% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.8% of its workObstetrics and Gynecology: 0 fractional works · 0.6% of its workDermatology: 0 fractional works · 0.5% of its workEpidemiology: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.3% of its workImmunology and Allergy: 0 fractional works · 0.2% of its workOtorhinolaryngology: 0 fractional works · 0.2% of its workTransplantation: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.7% of its workNursing: 2 fractional works · 5.5% of its workIssues, ethics and legal aspects: 2 fractional works · 5.5% of its workHealth Professions: 0 fractional works · 0.3% of its workPharmacy: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workLife Sciences: 8 fractional works · 22.2% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 18.2% of its workMolecular Biology: 5 fractional works · 13.3% of its workCell Biology: 1 fractional works · 3.2% of its workBiophysics: 0 fractional works · 0.9% of its workGenetics: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 1.5% of its workPlant Science: 0 fractional works · 0.9% of its workAgronomy and Crop Science: 0 fractional works · 0.3% of its workGeneral Agricultural and Biological Sciences: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workNeuroscience: 0 fractional works · 1.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.5% of its workSensory Systems: 0 fractional works · 0.5% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 0.7% of its workImmunology: 0 fractional works · 0.7% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.5% of its workPharmaceutical Science: 0 fractional works · 0.5% of its workSocial Sciences: 8 fractional works · 20.6% of its workSocial Sciences: 4 fractional works · 10.0% of its workPolitical Science and International Relations: 1 fractional works · 2.7% of its workEducation: 1 fractional works · 1.8% of its workCommunication: 0 fractional works · 1.4% of its workCultural Studies: 0 fractional works · 1.4% of its workSafety Research: 0 fractional works · 1.4% of its workDemography: 0 fractional works · 0.6% of its workSociology and Political Science: 0 fractional works · 0.3% of its workUrban Studies: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 1 fractional works · 3.8% of its workManagement of Technology and Innovation: 1 fractional works · 2.7% of its workManagement Information Systems: 0 fractional works · 0.6% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.5% of its workEconomics, Econometrics and Finance: 1 fractional works · 3.4% of its workEconomics and Econometrics: 1 fractional works · 3.4% of its workPsychology: 0 fractional works · 1.4% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.9% of its workSocial Psychology: 0 fractional works · 0.5% of its workArts and Humanities: 0 fractional works · 1.0% of its workLiterature and Literary Theory: 0 fractional works · 0.7% of its workPhilosophy: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 1.0% of its workInformation Systems and Management: 0 fractional works · 1.0% of its workPhysical Sciences: 7 fractional works · 20.5% of its workComputer Science: 3 fractional works · 7.2% of its workArtificial Intelligence: 2 fractional works · 4.9% of its workComputer Vision and Pattern Recognition: 0 fractional works · 1.4% of its workComputer Graphics and Computer-Aided Design: 0 fractional works · 0.5% of its workInformation Systems: 0 fractional works · 0.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.2% of its workEngineering: 2 fractional works · 6.2% of its workBiomedical Engineering: 1 fractional works · 2.8% of its workControl and Systems Engineering: 0 fractional works · 0.9% of its workOcean Engineering: 0 fractional works · 0.9% of its workCivil and Structural Engineering: 0 fractional works · 0.7% of its workArchitecture: 0 fractional works · 0.5% of its workComputational Mechanics: 0 fractional works · 0.5% of its workChemistry: 2 fractional works · 4.3% of its workOrganic Chemistry: 1 fractional works · 2.9% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.9% of its workSpectroscopy: 0 fractional works · 0.5% of its workMaterials Science: 0 fractional works · 1.2% of its workMaterials Chemistry: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 0.9% of its workBioengineering: 0 fractional works · 0.9% of its workEarth and Planetary Sciences: 0 fractional works · 0.7% of its workEarth-Surface Processes: 0 fractional works · 0.2% of its workGeochemistry and Petrology: 0 fractional works · 0.2% of its workGeology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workALL ITS WORKPharmatrophiX(United States)36fractional works, all years
Life Sciences22%Physical Sciences21%Health Sciences37%Social Sciences21%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine1130.9%
    2. Nursing25.5%
    3. Health Professions00.3%
    1. Biochemistry, Genetics and Molecular Biology718.2%
    2. Agricultural and Biological Sciences11.5%
    3. Neuroscience01.4%
    4. Immunology and Microbiology00.7%
    5. Pharmacology, Toxicology and Pharmaceutics00.5%
    1. Social Sciences410.0%
    2. Business, Management and Accounting13.8%
    3. Economics, Econometrics and Finance13.4%
    4. Psychology01.4%
    5. Arts and Humanities01.0%
    6. Decision Sciences01.0%
    1. Computer Science37.2%
    2. Engineering26.2%
    3. Chemistry24.3%
    4. Materials Science01.2%
    5. Chemical Engineering00.9%
    6. Earth and Planetary Sciences00.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.63× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.56× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 1.76× its world share, 0 worksImmunology and Micro…Neuroscience: 1.84× its world share, 0 worksNeuroscienceChemical Engineering: 8.60× its world share, 0 worksChemical EngineeringComputer Science: 2.03× its world share, 2 worksComputer ScienceEngineering: 0.10× its world share, 0 worksEngineeringHealth Professions: 0.11× its world share, 0 worksHealth ProfessionsMedicine: 1.74× its world share, 4 worksMedicineArts and Humanities: 0.06× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.78× its world share, 0 worksBusiness, Management…Decision Sciences: 3.29× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.64× its world share, 0 worksEconomics, Econometr…Psychology: 1.48× its world share, 0 worksPsychologySocial Sciences: 0.58× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemical Engineering, 8.6×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Chemical Engineering8.60×0 works
  2. Biochemistry, Genetics and Molecular Biology3.56×2 works
  3. Decision Sciences3.29×0 works
  4. Computer Science2.03×2 works
  5. Neuroscience1.84×0 works
  6. Immunology and Microbiology1.76×0 works
  7. Medicine1.74×4 works
  8. Psychology1.48×0 works
  9. Business, Management and Accounting0.78×0 works
  10. Economics, Econometrics and Finance0.64×0 works
  11. Agricultural and Biological Sciences0.63×0 works
  12. Social Sciences0.58×1 works
  13. Health Professions0.11×0 works
  14. Engineering0.10×0 works
  15. Arts and Humanities0.06×0 works

What are the most cited papers from PharmatrophiX (United States)?

The most cited paper from PharmatrophiX (United States) is "Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart failUre PaTiEnts Trial" (Ernest L. Mazzaferri, Siniša Gradinac, Dragan Sagić et al., 2012), with 70 citations. Next come "p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial" (62) and "The PARACHUTE IV trial design and rationale: Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure and dilated left ventricles" (61).

Most cited papers
#PaperReleasedCitations
1 Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart failUre PaTiEnts Trial Ernest L. Mazzaferri, Siniša Gradinac, Dragan Sagić et al. · American Heart Journal May 2012 70
2 p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial Hayley R. C. Shanks, Kewei Chen, Eric M. Reiman et al. · Nature Medicine Open access 17 May 2024 62
3 The PARACHUTE IV trial design and rationale: Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure and dilated left ventricles Marco Antonio Costa, Michael J. Pencina, Serjan D. Nikolic et al. · American Heart Journal 19 Feb 2013 61
4 Patient-specific finite element modeling of the Cardiokinetix Parachute® device: effects on left ventricular wall stress and function Lik Chuan Lee, Liang Ge, Zhihong Zhang et al. · Medical & Biological Engineering & Computing Open access 2 May 2014 47
5 Percutaneous Implantation of an Intraventricular Device for the Treatment of Heart Failure: Experimental Results and Proof of Concept Serjan D. Nikolic, Alex Khairkhahan, Miho Ryu et al. · Journal of Cardiac Failure 12 Jul 2009 31
All 39 most cited papers, with filters and sorting

Which keywords describe research at PharmatrophiX (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Health Policy, International Law, Nursing Advocacy, Public Health, Big Data, Fertility Preservation, Ovarian Tissue Cryopreservation and Artificial Intelligence.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Public Health2▲ 4.5×4 topics
  2. Health Policy2▲ 36×1 topic
  3. International Law2▲ 20×2 topics
  4. Machine Learning2▲ 2.6×7 topics
  5. Nursing Advocacy2▲ 299×1 topic
  6. Big Data2▲ 8.7×3 topics
  7. Artificial Intelligence2▲ 5.3×5 topics
  8. Fertility Preservation2▲ 57×1 topic
  9. Ovarian Tissue Cryopreservation2▲ 57×1 topic
  10. Oxidative Stress2▲ 2.2×9 topics
  11. Biosensors1▲ 6.4×3 topics
  12. Education1▲ 2.7×3 topics
  13. Corporate Governance1▲ 5.9×2 topics
  14. Heart Failure1▲ 7.5×6 topics
  15. Innovation1▲ 3.6×3 topics
  16. Myocardial Infarction1▲ 13×5 topics
  17. Sustainable Development1▲ 2.8×2 topics
  18. Economic Evaluation1▲ 23×2 topics
  19. Contractual Law1▲ 211×1 topic
  20. Financial Analysis1▲ 34×1 topic
  21. Health Claims1▲ 96×1 topic
  22. Intellectual Property Rights1▲ 59×1 topic
  23. Language1▲ 12×2 topics
  24. Monetary Policy1▲ 9.8×1 topic
  25. Obesity1▲ 3.8×7 topics
  26. Patent Analysis1▲ 161×1 topic
  27. Responsibility1▲ 56×1 topic
  28. Self-Assembly1▲ 7.0×2 topics
  29. scientific opinion1▲ 254×1 topic

Which research topics does PharmatrophiX (United States) publish most on?

By volume in 2022-now: Intelligent Tutoring Systems and Adaptive Learning, Monoclonal and Polyclonal Antibodies Research, Cardiovascular and exercise physiology and Advanced biosensing and bioanalysis techniques.

Intelligent Tutoring Systems and Adaptive Learning: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksCardiovascular and exercise physiology: 0 fractional worksAdvanced biosensing and bioanalysis techniques: 0 fractional worksRNA modifications and ca…0RNA modifications and cancer: 0 fractional worksNatural Language Processing Techniques: 0 fractional worksText Readability and Simplification: 0 fractional worksEmotion and Mood Recogni…0Emotion and Mood Recognition: 0 fractional worksCardiac Ischemia and Reperfusion: 0 fractional worksTopic Modeling0Topic Modeling: 0 fractional works
Artificial IntelligenceRadiology, Nuclear Medicine and ImagingComplementary and alternative medicineMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Intelligent Tutoring Systems and Adaptive Learning Artificial Intelligence 1 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Cardiovascular and exercise physiology Complementary and alternative medicine 0 works
  4. 4 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  5. 5 RNA modifications and cancer Molecular Biology 0 works
  6. 6 Natural Language Processing Techniques Artificial Intelligence 0 works
  7. 7 Text Readability and Simplification Artificial Intelligence 0 works
  8. 8 Emotion and Mood Recognition Experimental and Cognitive Psychology 0 works
  9. 9 Cardiac Ischemia and Reperfusion Pathology and Forensic Medicine 0 works
  10. 10 Topic Modeling Artificial Intelligence 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.7%not open69.3%

World: 40% of research is openly available.

with international co-authors22.1%domestic only77.9%

World: 18% is written across borders.

How has PharmatrophiX (United States)'s research output changed?

Output in 2022-2025 was 115% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is PharmatrophiX (United States) as a percentage of every work published that year, 0.000018% in 2024.

still counting0.00020%0.00040%0.00060%PharmatrophiX (United States)0.00011% in 20251990200020102020

Fractional works of PharmatrophiX (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Menlo Park

All research institutions in Menlo Park

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about PharmatrophiX (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.